Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lactobacillus fermentum + lactobacillus rhamnosus + lactobacillus plantarum + bifidobacterium longum
- Development stage
- Unknown
- Lead developer
- Biome Australia
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Lactobacillus fermentum + Lactobacillus rhamnosus + Lactobacillus plantarum + Bifidobacterium longum is a multi-strain probiotic combination composed of four specific bacterial strains: *Lactobacillus fermentum* LF16 (DSM 26956), *Lactobacillus rhamnosus* LR06 (DSM 21981), *Lactobacillus plantarum* LP01 (LMG P-21021), and *Bifidobacterium longum* BL04 (DSM 23233). Developed by Activated Probiotics and marketed under the brand name Biotic Mood, this live biotherapeutic product targets the gut-brain axis to improve sleep quality and manage mood disorders. Its mechanism of action involves the modulation of gut microbiota composition and the maintenance of host immune homeostasis, specifically by influencing cytokine balance and neurotransmitter signaling pathways associated with the gut-brain axis. It is typically administered orally in capsule form.
- Brand names
- Biotic Mood
- Other names
- LF16 + LR06 + LP01 + BL04
Beyond the preview
Go deeper on lactobacillus fermentum + lactobacillus rhamnosus + lactobacillus plantarum + bifidobacterium longum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lactobacillus fermentum + lactobacillus rhamnosus + lactobacillus plantarum + bifidobacterium longum.